BLU-667 (Pralsetinib) is a highly effective and selective RET inhibitor. It has an IC50 of 0.3-0.4 nM for the fusion of WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET.
Products > Drug Discovery > Inhibitor > Other Inhibitors | Products > Drug Discovery > Inhibitor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.